Research

https://pubs.acs.org/doi/10.1021/acs.jproteome.9b00470

https://www.ncbi.nlm.nih.gov/pubmed/31821002

Host Metabolic Response in Early Lyme Disease

https://www.sciencedirect.com/science/article/abs/pii/S0304416519302880?via%3Dihub

https://www.ncbi.nlm.nih.gov/pubmed/31785327

BBE31 from the Lyme disease agent Borrelia burgdorferi, known to play an important role in successful colonization of the mammalian host, shows the ability to bind glutathione.

BBE31 from the Lyme disease agent Borrelia burgdorferi shows the ability to bind glutathione: potentially opening doors to new strategies to fight against Lyme disease

https://www.nature.com/articles/s41598-019-53830-x

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879480/

https://www.ncbi.nlm.nih.gov/pubmed/31772280

Membrane directed expression in Escherichia coli of BBA57 and other virulence factors from the Lyme disease agent Borrelia burgdorferi

https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jiz626/5638890?redirectedFrom=fulltext

https://www.ncbi.nlm.nih.gov/pubmed/31758693

A novel laminin-binding protein mediates microbial-endothelial cell interactions and facilitates dissemination of Lyme disease pathogens

https://www.mdedge.com/ccjm/article/211289/infectious-diseases/appropriate-laboratory-testing-lyme-disease

https://www.ncbi.nlm.nih.gov/pubmed/31710588

Appropriate laboratory testing in Lyme disease

https://www.cmaj.ca/content/191/40/E1111?ijkey=1c206de9ad3ce738490061d59054ba68d2460473&keytype2=tf_ipsecsha

https://www.ncbi.nlm.nih.gov/pubmed/31844026

https://doi.org/10.1503/cmaj.1095806

Combatting Lyme disease myths and the “chronic Lyme industry”
Wendy Glauser
CMAJ October 07, 2019 191 (40) E1111-E1112; DOI: https://doi.org/10.1503/cmaj.1095806